Guangdong Hybribio Biotech Co.,Ltd.’s Net Profit Dropped 91.6% in First Half of 2023

Guangdong Hybribio Biotech Co.,Ltd. (广东凯普生物科技股份有限公司) (300639.SZ) reported a net profit of 89.4 million yuan in the first half of 2023, down 91.6% year-on-year.

Meanwhile, the company posted 606.6 million yuan in revenue, down 78.7% year-on-year.

At the end of the reporting period, it had 6.2 billion yuan in total assets and 1 billion yuan in total liabilities, with a liability-to-asset ratio of 16.7%.